NCT05379660

Brief Summary

With the development of surgical techniques, laparoscopic appendectomy has become a standard therapeutic procedure for acute appendicitis in many hospitals in recent years, which is considered as an effective and safe treatment option in children. Even so, patients still experience gastrointestinal dysfunction after surgery, which is one of the most common complications in patients who have undergone major abdominal surgery. The application of laparoscopy reduces trauma in some degree, however, postoperative nausea and vomiting (PONV), abdominal distension, fart, and delayed bowel movement caused by postoperative gastrointestinal dysfunction(PGD), severely disturb patients and seriously affect the quality of patients' postoperative recovery. Previous studies have shown that the incidence of PGD can be as high as 10%-30%. For PGD, the main treatment options include the use of gastric dynamics promoting drug, non-steroidal anti-inflammatory drug, gastrointestinal (GI) decompression, nutritional support, and so forth. However, the effect of these treatments is limited, and there are varying degrees of adverse reactions, which indirectly leads to the low satisfaction of patients. Acupuncture is a form of traditional Chinese medicine and has unique advantages in the treatment of PGD, which have gradually obtained more acceptance from physicians as an alternative therapy. While transcutaneous electrical acupoint stimulation (TEAS) is one of the acupuncture-related technologies and can allow for accurate control of stimulation parameters. For this reason, it is helpful for quantitative research and widely practiced in China. Many studies have shown that TEAS combining with anesthetics can significantly enhance the analgesic effect and reduce the dosage of anesthetics, and can offer certain beneficial effects, such as alleviating preoperative anxiety and reducing postoperative pain and PONV by lessening need for anesthetic usage. It also has been found to help protect the brain, heart and other tissues, with positive benefits for gastrointestinal function by regulating vasoactive intestinal peptide levels. In practice, however, the current TEAS study focused on adults,with relatively little research on their use in children. Because of that, we applied TEAS for use in our study to observe the effect of TEAS in children's laparoscopic surgery and explore its possible mechanism.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 4, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 18, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

June 30, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2023

Completed
Last Updated

May 18, 2022

Status Verified

May 1, 2022

Enrollment Period

6 months

First QC Date

May 4, 2022

Last Update Submit

May 17, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • the time to first bowel sound

    It was heard by the same researcher , and defined as the first time point at which the regular bowel sounds (more than two sounds every minute) are first heard after surgery.

    until the time point at which the regular bowel sounds are first heard after surgery up to 1 day

Secondary Outcomes (6)

  • the time to first passage of flatus

    an average of 24 hours,from the end of surgery to the time of the patient's first passage of flatus

  • the time to first passage of defecation

    an average of 24 hours,from the end of surgery to the the time of the patient's first passage of defecation,

  • the first time to normal diet intake

    within 48 hours after surgery,from the end of surgery to the time when the patient was given normal diet

  • the first time to mobilization

    within 48 hours after surgery,from the end of surgery to the time when the patient is first able to leave bed

  • gastroenterological hormones

    three time points: before induction of anesthesia, the end of the surgery and the first day after the operation

  • +1 more secondary outcomes

Study Arms (4)

T1 treatment group

EXPERIMENTAL

TEAS initiates at 30 minutes before induction and lasts for 30 minutes

Device: transcutaneous electrical acupoint stimulation

T2 treatment group

EXPERIMENTAL

TEAS initiates immediately after skin incision and lasts for 30 minutes

Device: transcutaneous electrical acupoint stimulation

T3 treatment group

EXPERIMENTAL

TEAS initiates immediately after extubating and lasts for 30 minutes

Device: transcutaneous electrical acupoint stimulation

control group

NO INTERVENTION

Electrodes are placed on the same acupoints, but no current is given

Interventions

Basing on the theory of traditional Chinese medicine, bilateral Zusanli (ST 36), Shangjuxu (ST 37) and Sanyinjiao (SP 6) are elected as the acupuncture points,the electrode pads with wire are attached to the corresponding acupoints, which are connected with Hwato electric acupuncture treatment instrument,TEAS stimulation uses a dense-dispersed wave with frequencies of 2 and 100 Hz alternating every 3 s, and the intensity 5 \~ 12mA,on the first and second days after surgery, the doctor who is responsible for acupuncture will arrive at the ward in the morning and afternoon to administer TEAS stimulation at the same acupoints for 30 min in the TEAS groups

T1 treatment groupT2 treatment groupT3 treatment group

Eligibility Criteria

Age4 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • American Society of Anesthesiologists grade I\&II,16kg/m2 ≤BMI≤30kg/m2, undergoing laparoscopic appendectomy

You may not qualify if:

  • previous history of gastrointestinal surgery or abnormal anesthesia recovery, allergy, broken and infection skin at and around the related points, long-term use of analgesic and sedative drugs, presence of severe systemic disease,and the patients drop out or are unable to complete a full follow-up for any reason

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Fang Li Yang

    Xi 'an children's hospital

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2022

First Posted

May 18, 2022

Study Start

June 30, 2022

Primary Completion

December 30, 2022

Study Completion

April 30, 2023

Last Updated

May 18, 2022

Record last verified: 2022-05